Patent Ductus Arteriosus Clinical Trials

Find Patent Ductus Arteriosus Clinical Trials Near You

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

Status: Recruiting
Location: See all (9) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart.

Eligibility
Participation Requirements
Sex: All
Minimum Age: Newborn
Maximum Age: 6 months
Healthy Volunteers: f
View:

• Parental or legal authorized representative provide consent for study enrollment

• Infants \< 6 months of age

• Diagnosis of congenital heart defect with ductal-dependent pulmonary circulation requiring infusion of prostaglandins

• Requires ductus arteriosus stent diameters of 3.5mm or 4mm and stent lengths between 16mm and 28mm

Locations
United States
California
UCLA Mattel Children's
RECRUITING
Los Angeles
Leland Stanford Junior University
RECRUITING
Stanford
Colorado
Children's Hospital Colorado
RECRUITING
Aurora
Massachusetts
Boston Children's Hospital
NOT_YET_RECRUITING
Boston
Ohio
Cincinnati Children's Hospital Medical Center
RECRUITING
Cincinnati
Nationwide Children's Hospital
RECRUITING
Columbus
Pennsylvania
Children's Hospital of Philadelphia
RECRUITING
Philadelphia
Texas
Texas Children's Hospital - Baylor College of Medicine
RECRUITING
Houston
Washington
Seattle Children's Hospital
RECRUITING
Seattle
Contact Information
Primary
Mary Beth Tate, BSBE-MBA
marybeth.tate@globalmedicaldeviceconsultants.com
734-709-2080
Time Frame
Start Date: 2026-01-16
Estimated Completion Date: 2028-04
Participants
Target number of participants: 45
Treatments
Other: Single Arm - Treatment
Treatment with the Lifeline Ductus Arteriosus Stent
Related Therapeutic Areas
Sponsors
Collaborators: National Institutes of Health (NIH)
Leads: Starlight Cardiovascular Inc

This content was sourced from clinicaltrials.gov